Dacogen is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is Decitabine.
Product ID | 59148-046_4d5b6a30-b467-4236-bef9-4c339aab5921 |
NDC | 59148-046 |
Product Type | Human Prescription Drug |
Proprietary Name | Dacogen |
Generic Name | Decitabine |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2006-05-02 |
Marketing Category | NDA / NDA |
Application Number | NDA021790 |
Labeler Name | Otsuka America Pharmaceutical, Inc. |
Substance Name | DECITABINE |
Active Ingredient Strength | 50 mg/20mL |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2006-05-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021790 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-05-02 |
Ingredient | Strength |
---|---|
DECITABINE | 50 mg/20mL |
SPL SET ID: | deb4a13c-855b-4372-9778-6e81da598df6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
59148-046 | Dacogen | decitabine |
0143-9385 | decitabine | decitabine |
0781-3139 | Decitabine | Decitabine |
0781-3296 | Decitabine | Decitabine |
16714-749 | Decitabine | Decitabine |
16714-928 | Decitabine | Decitabine |
16729-224 | Decitabine | decitabine |
25021-231 | decitabine | decitabine |
42737-110 | Decitabine | Decitabine |
43598-348 | Decitabine | Decitabine |
43598-427 | Decitabine | Decitabine |
47335-361 | decitabine | decitabine |
50742-430 | DECITABINE | decitabine |
55111-556 | Decitabine | Decitabine |
55150-376 | Decitabine | Decitabine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DACOGEN 78216191 3197209 Live/Registered |
ASTEX PHARMACEUTICALS, INC. 2003-02-18 |